Ironwood Pharmaceuticals Stock In The News

IRWD Stock  USD 8.71  0.09  1.04%   
The overall news coverage of Ironwood Pharmaceuticals from major news outlets shows bullish sentiment on 10 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Ironwood Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Ironwood Pharmaceuticals. The specific impact of Ironwood Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ironwood Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ironwood Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ironwood Pharmaceuticals Backtesting and Ironwood Pharmaceuticals Hype Analysis.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.

Ironwood Pharmaceuticals Today Top News and Investor Outlook

Yahoo News
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
https://finance.yahoo.com/news/opko-health-opk-entera-bio-135700423.html
 Bullish
sbwire news
It's Time! 3 Failing Biotech Stocks to Sell Right Now
https://investorplace.com/2024/03/its-time-3-failing-biotech-stocks-to-sell-right-now/
 Bullish
sbwire news
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
https://investorplace.com/2024/02/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-feb-29th/
 Bullish
sbwire news
Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?
https://investorplace.com/2024/02/why-is-ironwood-pharmaceuticals-irwd-stock-down-27-today/
 Bearish
Yahoo News
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
https://finance.yahoo.com/news/ironwood-pharmaceuticals-present-four-abstracts-123000676.html
 Neutral
Yahoo News
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
https://finance.yahoo.com/news/ironwood-pharmaceuticals-full-2023-earnings-125019126.html
 Neutral
Yahoo News
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
https://finance.yahoo.com/news/ironwood-pharmaceuticals-inc-nasdaq-irwd-151546535.html
 Bullish
Yahoo News
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
https://finance.yahoo.com/news/ironwood-irwd-q4-earnings-miss-143600493.html
 Bullish
Yahoo News
Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call
https://finance.yahoo.com/news/q4-2023-ironwood-pharmaceuticals-inc-034513393.html
 Bullish
Yahoo News
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
https://finance.yahoo.com/news/ironwood-pharmaceuticals-irwd-reports-break-131502250.html
 Bullish

Ironwood Pharmaceuticals Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ironwood and other traded companies coverage. We help investors stay connected with Ironwood headlines for the 29th of March to make an informed investment decision based on correlating the impacts of news items on Ironwood Stock performance. Please note that trading solely based on the Ironwood Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ironwood Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ironwood Pharmaceuticals investors visualize upcoming and past events in order to time the market based on Ironwood Pharmaceuticals noise-free hype analysis.
Ironwood Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ironwood earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ironwood Pharmaceuticals that are available to investors today. That information is available publicly through Ironwood media outlets and privately through word of mouth or via Ironwood internal channels. However, regardless of the origin, that massive amount of Ironwood data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ironwood Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ironwood Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ironwood Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ironwood Pharmaceuticals alpha.

Ironwood Largest EPS Surprises

Earnings surprises can significantly impact Ironwood Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-05-06
2020-03-310.050.04-0.0120 
2011-05-12
2011-03-31-0.17-0.19-0.0211 
2011-03-03
2010-12-31-0.14-0.120.0214 
2021-05-06
2021-03-310.210.240.0314 
2018-05-01
2018-03-31-0.23-0.27-0.0417 
2018-02-15
2017-12-31-0.18-0.140.0422 
View All Earnings Estimates

Ironwood Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ironwood Pharmaceuticals Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Investing News at Macroaxis
28th of March 2024
Ironwood Pharmaceuticals reports positive apraglutide trial results
at investing.com 
zacks News
25th of March 2024
OPKO Health And Entera Bio Announce Data for GLP-2
at zacks.com 
news
22nd of March 2024
Disposition of 2322 shares by Shetzline Michael of Ironwood Pharmaceuticals at 11.41 subje...
at accesswire.com 
news
19th of March 2024
IMPORTANT INVESTOR ALERT The Schall Law Firm Announces it is Investigating Claims Against ...
at accesswire.com 
news
13th of March 2024
SHAREHOLDER ACTION ALERT The Schall Law Firm Announces it is Investigating Claims Against ...
at accesswire.com 
news
8th of March 2024
Ironwood Pharmaceuticals Stock Rating Upgraded by StockNews.com
at thelincolnianonline.com 
news
7th of March 2024
Ironwood Pharmaceuticals, Inc. Short Interest Update
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
6th of March 2024
Ironwood Pharmaceuticals Inc CFO Sravan Emany Acquires 10,684 Shares
at gurufocus.com 
news
5th of March 2024
Ironwood Pharmaceuticals Given New 14.00 Price Target at Wells Fargo Company
at thelincolnianonline.com 
Yahoo News
29th of February 2024
UPDATE 1-Ironwoods bowel disease treatment meets main goal in late-stage trial
at finance.yahoo.com 
news
15th of February 2024
Ironwood Pharmaceuticals, Inc. CMO Michael Shetzline Sells 38,618 Shares of Stock
at thelincolnianonline.com 
news
19th of January 2024
Ironwood Pharmaceuticals Trading 5.2 percent Higher
at thelincolnianonline.com 

Ironwood Pharmaceuticals Investors Sentiment

The influence of Ironwood Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ironwood. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ironwood Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ironwood. The trend in average sentiment can be used to explain how an investor holding Ironwood can time the market purely based on public headlines and social activities around Ironwood Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ironwood Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ironwood Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ironwood Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ironwood Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ironwood Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ironwood Pharmaceuticals' short interest history, or implied volatility extrapolated from Ironwood Pharmaceuticals options trading.
When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:
Check out Ironwood Pharmaceuticals Backtesting and Ironwood Pharmaceuticals Hype Analysis.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Ironwood Stock analysis

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Is Ironwood Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.69)
Earnings Share
(6.45)
Revenue Per Share
2.848
Quarterly Revenue Growth
0.097
Return On Assets
0.1339
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.